Robotic Resection Outperforms Laparoscopic for Minor Liver Surgery
Robotic minor liver resection shows significant benefits over laparoscopic approaches for anterolateral segment surgeries.
Newsletter
HPB & Spleen
Every new paper in this field, in your inbox.
New Tool Improves Fistula Risk Prediction in Pancreatoduodenectomy
A newly optimized classification model better predicts postoperative pancreatic fistula risk in patients undergoing pancreatoduodenectomy for periampullary tumors.
Critical Margin Assessment in Pancreatic Cancer Surgery
Surgeons must prioritize evaluating specific resection margins in pancreatic cancer for better patient outcomes.
EUS-RFA Offers Safe Option for Intraductal Neoplasms
EUS-guided radiofrequency ablation is a safe alternative for patients with branch-duct IPMNs showing worrisome features who cannot undergo surgery.
Laparoscopic Approach to Complex Liver Resection for Cholangiocarcinoma
Laparoscopic hemi-hepatectomy with portal vein resection offers effective options for patients with perihilar cholangiocarcinoma and portal vein involvement.
Laparoscopic Sectionectomy: Safe, Low-Cost Technique In Action
A new laparoscopic posterior sectionectomy approach demonstrates effective liver resection while minimizing costs and resource use.
Adjuvant Radiotherapy Boosts Survival in Node-Positive PDAC
Adjuvant radiotherapy improves survival for patients with margin-negative, node-positive pancreatic ductal adenocarcinoma after surgery.
Socioeconomic Disadvantage Cuts Survival in Pancreatic Cancer
Living in socioeconomically disadvantaged areas significantly reduces survival in patients with nonmetastatic pancreatic cancer, even with guideline-concordant treatment.
Noninvasive Liver Tests Identify Surgical Risks in CRLM Patients
Noninvasive tests for liver fibrosis can predict complications in colorectal liver metastases surgery.
Intraoperative CO2 Levels Impact Survival in Pancreatic Cancer
Monitoring end-tidal carbon dioxide (etCO2) during pancreaticoduodenectomy can guide surgical decisions and improve patient outcomes in pancreatic ductal adenocarcinoma (PDAC).